Related Experiment Videos
[Initial experience in percutaneous closure of interatrial communication with the amplatzer device]
V F Fontes1, C A Pedra, S R Pedra
1Instituto Dante Pazzanese de Cardiologia.
Insights
Percutaneous closure of atrial septal defects (ASD) using the Amplatzer septal occluder is a safe and effective treatment. This minimally invasive procedure offers a versatile alternative for selected patients, with excellent closure rates.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Context:
- Atrial septal defects (ASD) are common congenital heart abnormalities.
- Traditional surgical closure carries risks.
- Percutaneous closure offers a less invasive alternative.
Purpose:
- To evaluate the initial experience with percutaneous closure of secundum atrial septal defects (ASD).
- To assess the safety and efficacy of the Amplatzer septal occluder for ASD treatment.
Summary:
- Seven patients underwent percutaneous closure of ASD using the Amplatzer septal occluder.
- The procedure was performed via an anterograde approach with transesophageal echocardiography guidance.
- Eight devices were successfully implanted in 7 patients, with complete defect occlusion and same-day discharge.
Impact:
- Percutaneous ASD closure with the Amplatzer device is safe and effective.
- This technique provides a versatile initial treatment option for selected ASD patients.
- Minimally invasive closure leads to rapid recovery and excellent outcomes.
Purpose:
To evaluate our initial experience with percutaneous closure of secundum type atrial septal defects (ASD) with the Amplatzer septal occluder.
Methods:
Seven patients underwent occlusion by anterograde approach, under general anesthesia and transesophageal echocardiography (TEE) guidance. One child had 2 ASD and a patent ductus arteriosus (PDA). The ASD size ranged from 8.7 to 20 mm as measured by TEE. A transthoracic echocardiogram was performed in the morning after the procedure.
Results:
Eight devices were successfully implanted in 7 patients and the PDA was occluded with a Gianturco coil at the same session. In this patient, there was an episode of supraventricular tachycardia during the occlusion of one ASD which was reverted with adenosin. All patients were discharged the day after, with complete occlusion of all defects.
Conclusion:
The procedure is safe, effective and versatile. It can be applied as an initial alternative to the treatment of selected patients with ASD.